• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同抗炎药物对类风湿关节炎患者滑液中前列腺素浓度影响的比较。

Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.

作者信息

Seppälä E, Nissilä M, Isomäki H, Nuotio P, Nykänen E, Laitinen O, Vapaatalo H

出版信息

Clin Rheumatol. 1985 Sep;4(3):315-20. doi: 10.1007/BF02031615.

DOI:10.1007/BF02031615
PMID:3864577
Abstract

The effects of one-day treatment with nine nonsteroidal anti-inflammatory drugs and prednisolone on human synovial fluid concentrations of prostanoids were studied. The doses were calculated so as to be approximately equipotent according to clinical experience and the recommendations of the manufacturers. Most of the drugs used reduced clearly PGE2 and TxB2 levels in synovial fluid, but only a slight diminution in 6-keto-PGF1 alpha values was found. Carprofen, diclofenac, indomethacin, naproxen and tolfenamic acid reduced significantly the synovial fluid PGE2 concentrations. Diclofenac and indomethacin also reduced significantly the synovial TxB2 concentrations.

摘要

研究了九种非甾体抗炎药和泼尼松龙一日治疗对人滑液中前列腺素浓度的影响。根据临床经验和制造商的建议计算剂量,使其大致等效。所使用的大多数药物明显降低了滑液中PGE2和TxB2的水平,但仅发现6-酮-PGF1α值略有降低。卡洛芬、双氯芬酸、吲哚美辛、萘普生和托芬那酸显著降低了滑液中PGE2的浓度。双氯芬酸和吲哚美辛也显著降低了滑液中TxB2的浓度。

相似文献

1
Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.不同抗炎药物对类风湿关节炎患者滑液中前列腺素浓度影响的比较。
Clin Rheumatol. 1985 Sep;4(3):315-20. doi: 10.1007/BF02031615.
2
Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs.十种非甾体抗炎药镇痛效果的比较
Br J Rheumatol. 1984 Feb;23(1):61-5. doi: 10.1093/rheumatology/23.1.61.
3
Production of prostanoids by rheumatic synovial cells in vitro: effects of anti-inflammatory drugs on arachidonic acid metabolism.风湿性滑膜细胞体外前列腺素的产生:抗炎药物对花生四烯酸代谢的影响。
Clin Rheumatol. 1987 Jun;6(2):170-6. doi: 10.1007/BF02201019.
4
Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis.炎症性关节疾病和骨关节炎患者滑液中前列腺素D2、E2、F2α、6-酮-F1α和血栓素B2的浓度。
Z Rheumatol. 1984 Mar-Apr;43(2):89-96.
5
Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.萘普生钠:对人类风湿性滑液中炎症反应介质的浓度及影响
Eur J Clin Pharmacol. 1994;46(1):3-7. doi: 10.1007/BF00195907.
6
Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.类风湿性关节炎患者体内前列腺素的血浆水平及尿排泄情况。
Clin Rheumatol. 1983 Dec;2(4):401-6. doi: 10.1007/BF02041562.
7
Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis.类风湿关节炎关节液中前列腺素F2α、E2及血栓素B2的水平
Scand J Rheumatol. 1977;6(3):151-4. doi: 10.3109/03009747709095440.
8
Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.双氯芬酸、吲哚美辛、托芬那酸及氢化可的松对健康和风湿性滑膜细胞中前列腺素生成的影响。
Agents Actions. 1989 Mar;26(3-4):342-9. doi: 10.1007/BF01967299.
9
Validation of the direct radioimmunoassay of prostanoids in serum and kidney.血清和肾脏中前列腺素直接放射免疫测定法的验证
Prostaglandins Leukot Med. 1984 Apr;14(1):55-64. doi: 10.1016/0262-1746(84)90024-6.
10
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs.慢性炎症性关节炎中的滑膜前列腺素系统:甾体类和非甾体类抗炎药的不同作用
Br J Pharmacol. 1981 Aug;73(4):893-901. doi: 10.1111/j.1476-5381.1981.tb08743.x.

引用本文的文献

1
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.对乙酰氨基酚(扑热息痛):一种作用机制不明的常见药物。
Temperature (Austin). 2021 Mar 16;8(4):351-371. doi: 10.1080/23328940.2021.1886392. eCollection 2021.
2
Safe and appropriate use of diclofenac in chronic kidney disease: An Indian perspective.双氯芬酸在慢性肾脏病中的安全合理应用:印度视角
J Family Med Prim Care. 2021 Jul;10(7):2450-2456. doi: 10.4103/jfmpc.jfmpc_2358_20. Epub 2021 Jul 30.
3
Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy.

本文引用的文献

1
A new antiinflammatory compound, timegadine (N-cyclohexyl-N"-4-[2-methylquinolyl]-N'-2-thiazolylguanidine), which inhibits both prostaglandin and 12-hydroxyeicosatetraenoic acid (12-HETE) formation.一种新的抗炎化合物,替马加定(N-环己基-N''-4-[2-甲基喹啉基]-N'-2-噻唑基胍),它能抑制前列腺素和12-羟基二十碳四烯酸(12-HETE)的形成。
Biochem Pharmacol. 1980 Dec;29(24):3265-9. doi: 10.1016/0006-2952(80)90301-9.
2
Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs.十种非甾体抗炎药镇痛效果的比较
Br J Rheumatol. 1984 Feb;23(1):61-5. doi: 10.1093/rheumatology/23.1.61.
3
Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.
孕期吲哚美辛处置的基于生理的药代动力学/药效学模型的建立。
PLoS One. 2015 Oct 2;10(10):e0139762. doi: 10.1371/journal.pone.0139762. eCollection 2015.
4
Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.非甾体抗炎药(NSAID)的发展进展:运用制药技术的双氯芬酸产品的演变
Drugs. 2015 May;75(8):859-77. doi: 10.1007/s40265-015-0392-z.
5
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.对乙酰氨基酚的现代药理学:治疗作用、作用机制、代谢、毒性和最近的药理学发现。
Inflammopharmacology. 2013 Jun;21(3):201-32. doi: 10.1007/s10787-013-0172-x. Epub 2013 May 30.
6
Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients.类风湿性关节炎和骨关节炎患者滑液中的环磷酸腺苷
Rheumatol Int. 2008 Dec;29(2):167-71. doi: 10.1007/s00296-008-0663-z. Epub 2008 Aug 10.
7
Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.双氯芬酸的临床药代动力学。治疗见解与陷阱。
Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003.
8
A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.注射用非甾体抗炎药用于术后疼痛管理的风险效益评估。
Drug Saf. 1993 Nov;9(5):380-93. doi: 10.2165/00002018-199309050-00006.
9
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.双氯芬酸钠。对其药效学和药代动力学特性以及治疗效果的重新评估。
Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004.
10
Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin-1.双氯芬酸对白细胞介素-1刺激的人滑膜成纤维细胞产生前列腺素E和透明质酸的影响。
Br J Clin Pharmacol. 1989 Aug;28(2):193-6. doi: 10.1111/j.1365-2125.1989.tb05416.x.
类风湿性关节炎患者体内前列腺素的血浆水平及尿排泄情况。
Clin Rheumatol. 1983 Dec;2(4):401-6. doi: 10.1007/BF02041562.
4
A modified method for extraction and purification of prostaglandins with resin XAD-2.一种用XAD - 2树脂提取和纯化前列腺素的改良方法。
Prostaglandins Leukot Med. 1984 May;14(2):235-41. doi: 10.1016/0262-1746(84)90207-5.
5
Differences in the production of arachidonic acid metabolites between healthy and rheumatic synovial fibroblasts in vitro. A preliminary study.体外培养的健康与风湿性滑膜成纤维细胞花生四烯酸代谢产物生成的差异:一项初步研究。
Scand J Rheumatol. 1984;13(3):243-6. doi: 10.3109/03009748409100393.
6
Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture.类风湿性和非类风湿性滑膜衬里在非增殖性器官培养中花生四烯酸环氧化酶产物的合成。
Ann Rheum Dis. 1983 Feb;42(1):36-9. doi: 10.1136/ard.42.1.36.
7
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.人体滑液和滑膜组织中的抗风湿药物浓度。关于血管外药代动力学的观察。
Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002.
8
Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation.花生四烯酸代谢产物的免疫调节活性及其在炎症中的作用。
Br Med Bull. 1983 Jul;39(3):243-8. doi: 10.1093/oxfordjournals.bmb.a071827.
9
Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.
Agents Actions. 1982 Oct;12(4):516-20. doi: 10.1007/BF01965936.
10
Cyclic nucleotides and modulation of effector systems of inflammation.环核苷酸与炎症效应系统的调节
Biochem Pharmacol. 1974 Feb 15;23(4):763-71. doi: 10.1016/0006-2952(74)90206-8.